AGAR Group

Menu

2020 Meetings

December 2020 Meeting:

AGAR EXECUTIVE AGENDA DECEMBER 2020 (PDF)
AGAR EXECUTIVE MEETING MINUTES DECEMBER 2020 (PDF)
AGAR EXECUTIVE MEETING MINUTES JULY 2020 (PDF)
4.1 AURA TRANSITION TO DOH LARA PURDY LETTER TO PROFESSOR COOMBS (PDF)
4.2 LARA PURDY TO PROFESSOR MELEADY RE AURA DATA FOR GLASS (PDF)
4.3 AGAR EXECUTIVE 2020 TO 2023 (PDF)
4.4 AGAR EXECUTIVE CHAIR AND DEPUTY CHAIR (PDF)
4.5 AGE-ADJUSTED MORTALITY (PDF)
4.6 LINDA DOUGLASS (PDF)
5.0 AGAR 2020 OPERATING PROCEDURES (PDF)
6.0 AGAR 2020 DATA GOVERNANCE AND MANAGEMENT PLAN ACSQHC (PDF)
7.1 JUNE 2020 AGAR FINANCIAL REPORT (PDF)
7.2 2019 2020 AGAR FINANCIAL REPORT (PDF)
7.3 SEPTEMBER 2020 AGAR FINANCIAL REPORT (PDF)
8.1 GNSOP 2018 CDI REPORT (PDF)
9.1 AGAR 2019 PROGRAM BUDGET (PDF)
9.2 ASSOP 2019 ACSQHC REPORT (PDF)
9.2 ASSOP 2019 ACSQHC REPORT (PDF)
9.4 GNSOP 2019 ACSQHC REPORT (PDF)
9.5 AGAR 2019 AMALGAM DRAFT ACSQHC REPORT (PDF)
9.6 ASSOP 2019 CDI REPORT (PDF)
9.7 AESOP 2019 CDI REPORT (PDF)
9.8 GNSOP 2019 CDI REPORT (PDF)
10.1 AGAR 2020 PROJECT PLAN ACSQHC (PDF)
10.2 CONTRACT 1 JULY 31 TO DECEMBER 2020 ACSQHC (PDF)
10.3 CONTRACT JAN BELL ACSQHC (PDF)
10.4 2020 AGAR PROGRAM BUDGET (PDF)
10.5 AGAR 2020 ATM (PDF)
13.1 MRSA BACTERAEMIA IN AUSTRALIA 2013 TO 2018 (PDF)
15.1 PLAN FOR AGAR DATA IN CHILDREN PENELOPE BRYANT (PDF)
16.1 GLASS WGS SURVEILLANCE OF AMR (PDF)
16.2 ANIMAL INDUSTRIES AMS (PDF)
16.3 OUTBREAK MRFF (PDF)

July 2020 Meeting:

AGAR EXECUTIVE AGENDA JULY 2020 (PDF)
AGAR EXECUTIVE MEETING MINUTES JULY 2020 (PDF)
AGAR EXECUTIVE MEETING MINUTES NOVEMBER 2019 (PDF)
4.1 2018 AGAR SEPSIS OUTCOME REPORT (PDF)
4.2. AGAR EC_KP PROJECT (PDF)
4.3. AGE ADJUSTMENT OF MORTALITY (PDF)
4.4. ROYAL MELBOURNE HOSPITAL (PDF)
4.5. BRONWYN THOMSETT (PDF)
4.6. DAVID MCGECHIE (PDF)
4.7. AGAR OUTBREAK REQUEST (PDF)
5.1 AGAR OPERATING PROCEDURES 2020 (PDF)
7.1. AGAR DECEMBER 2019 FINANCIAL REPORT (PDF)
7.2. AGAR MARCH 2020 FINANCIAL REPORT (PDF)
8.1. 2019 AGAR BUDGET (PDF)
8.2. ACSQHC CEO LETTER (PDF)
8.3. PROPOSED 2020 AGAR BUDGET (PDF)
8.4. CONTRACT – AURA – ASA FOR AGAR – 1 JULY 31 TO DECEMBER 2020 (1) (PDF)
8.5. AGAR 2020 DATA MANAGEMENT PLAN (PDF)
10.1 AESOP 2018 CDI (PDF)
10.2 ASSOP 2018 CDI (PDF)
11.1 ASSOP 2019 PRELIMINARY REPORT (PDF)
11.2. AESOP 2019 PRELIMINARY REPORT (PDF)
11.3. GNSOP 2019 PRELIMINARY REPORT (PDF)
11.4. GNSOP 2019 SUMMARY JULY 2019 (PDF)
11.5. GNSOP 2019 WORKFLOW (PDF)
13.1. SEPARATE AGAR FROM HHCAPP CDA (PDF)
14.1. CARALERT 2019 ANNUAL REPORT (PDF)
15.1. PUBLICATION OF THE 2020 AMR STRATEGY (PDF)
15.2. NATIONAL ANTIMICROBIAL RESISTANCE STRATEGY 2020 BEYOND (PDF)
15.3. REVISED DRAFT OHMAP (PDF)
15.3.1. ATTACHMENT A – REVISED ONE HEALTH MASTER ACTION PLAN (LAST UPDATED 13052020) (PDF)
15.3.2. ATTACHMENT B – FOCUS AREAS PRE- AND POST-25 NOV 2019 ASTAG WORKSHOP – ONE HEALTH MASTER ACTION PLAN (PDF)
15.3.3. ATTACHMENT C – SURVEY AND WORKSHOP TABLE RESPONSES – 25 NOV 2019 ASTAG WORKSHOP – DE-IDENTIFIED COPY (PDF)
16.1. GN SEPSIS PAEDS (PDF)

Copyright © 2004-2022 Australian Group on Antimicrobial Resistance (AGAR). Last Updated December 2017.